Synthesis of MMP inhibitor radiotracers [11C]methyl-CGS 27023A and its analogs, new potential PET breast cancer imaging agents
- 27 March 2002
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 45 (6), 449-470
- https://doi.org/10.1002/jlcr.570
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MMP Inhibitor radiotracer [11C]methyl‐CGS 27023A: A new pet breast cancer imaging agentJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- Potent and Selective Mechanism-Based Inhibition of GelatinasesJournal of the American Chemical Society, 2000
- Design and Synthesis of Phosphinamide-Based Hydroxamic Acids as Inhibitors of Matrix MetalloproteinasesJournal of Medicinal Chemistry, 1998
- Discovery of Potent, Achiral Matrix Metalloproteinase InhibitorsJournal of Medicinal Chemistry, 1998
- Highly Selective and Orally Active Inhibitors of Type IV Collagenase (MMP-9 and MMP-2): N-Sulfonylamino Acid DerivativesJournal of Medicinal Chemistry, 1998
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in RabbitsJournal of Medicinal Chemistry, 1997
- Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and MarimastatPharmacology & Therapeutics, 1997
- Improved synthesis of β-CIT and [11C]β-CIT labeled at nitrogen or oxygen positionsNuclear Medicine and Biology, 1996
- Stromelysin-3 expression in breast cancer biopsies: Clinico-pathological correlationsInternational Journal of Cancer, 1993